Rosuvastatin for reduction of myocardial damage during coronary intervention /
تأثير عقار روزيوفاستاتين للحد من نسبة حدوث تلف عضلة القلب أثناء القسطرة التداخلية للشرايين التاجية
Ahmed Abdelazim Mohamed Kenawy ; Supervised Hesham Salah Eldin Taha , Mohamed Salah Eldin Zaki Elramly , Sameh Ahmed Salama
- Cairo : Ahmed Abdelazim Mohamed Kenawy , 2014
- 108 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology
Objectives: A high loading dose of statins has been showed to reduce post procedural events in patients undergoing percutaneous coronary intervention (PCI). In this study, we investigated the possible protective effects of rosuvastatin in Egyptian patients with stable or unstable angina undergoing PCI. Results: In our study, we found that loading dose of rosuvastatin 20 mg was associated with a reduction of periprocedural myonecrosis more than chronic statin therapy and both of them were associated with a reduction of periprocedural myonecrosis more than non-statins users in patients with stable or unstable angina
Elective PCI Rosuvastatin Stable or Unstable Angina